Emergent BioSolutions Inc. Financial Ratios
EBS / Health Care|FY2025 SEC 10-K data
Includes DuPont ROE decomposition, profitability margins, liquidity ratios, solvency indicators, and earnings quality analysis. All ratios calculated from FY2025 SEC 10-K data.
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
DuPont ROE Decomposition (FY2025)
Return on Equity
10.1%
ROE ranks in the below average among Health Care companies
Profit Margin
7.1%
Net Income / Revenue
Asset Turnover
0.56
Revenue / Total Assets
Equity Multiplier
2.52
Total Assets / Equity
Composite: 10.1% (reported: 10.1%)
Profitability
Liquidity
Current Ratio
5.01
Quick Ratio
2.41
Solvency
Interest Coverage
-
Efficiency
Asset Turnover
0.56
Inventory Turnover
0.95
Days Sales Outstanding
41 days
As of FY2025 · SEC 10-K · Updated Jul 2, 2026
Earnings Quality
Accrual Ratio
-8.7%
+9.2pp YoY
Earnings are primarily supported by operating cash flow.
This metric is for informational purposes only and does not constitute investment advice. Data sourced from SEC EDGAR filings; updates may be delayed.